PHARMACOKINETICS OF RILMENIDINE IN HEALTHY-SUBJECTS

[1] GAS-CHROMATOGRAPHIC NEGATIVE-ION MASS-SPECTROMETRIC ASSAY OF 2-DICYCLOPROPYLMETHYLAMINO-2-OXAZOLINE (S-3341), A NEW ANTIHYPERTENSIVE DRUG [J]. BIOMEDICAL MASS SPECTROMETRY, 1985, 12 (10): : 593 - 595

[2] FILLASTRE JP, 1987, 3RD EUR M HYP MIL

[3] GIBALDI M, 1984, BIOPHARMACEUTICS CLI

[4] GUICHENEY P, 1981, J PHARMACOL-PARIS, V12, P255

[5] LAUBIE M, 1985, J PHARMACOL-PARIS, V16, P259

[6] INFLUENCE OF FOOD ON BIOAVAILABILITY OF DRUGS [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (05) : 337 - 351

[7] MURRAY S, 1985, BIOMED MASS SPECTROM, V12, P230, DOI 10.1002/bms.1200120509

[8] NON-COMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION FOR ANY MODE OF ADMINISTRATION [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (03) : 372 - 373

[9] Rowland M, 1980, CLIN PHARMACOKINETIC

[10] SPRIET A, 1978, EUR J DRUG METAB PH, V2, P129

[1] GAS-CHROMATOGRAPHIC NEGATIVE-ION MASS-SPECTROMETRIC ASSAY OF 2-DICYCLOPROPYLMETHYLAMINO-2-OXAZOLINE (S-3341), A NEW ANTIHYPERTENSIVE DRUG [J]. BIOMEDICAL MASS SPECTROMETRY, 1985, 12 (10): : 593 - 595

[2] FILLASTRE JP, 1987, 3RD EUR M HYP MIL

[3] GIBALDI M, 1984, BIOPHARMACEUTICS CLI

[4] GUICHENEY P, 1981, J PHARMACOL-PARIS, V12, P255

[5] LAUBIE M, 1985, J PHARMACOL-PARIS, V16, P259

[6] INFLUENCE OF FOOD ON BIOAVAILABILITY OF DRUGS [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (05) : 337 - 351

[7] MURRAY S, 1985, BIOMED MASS SPECTROM, V12, P230, DOI 10.1002/bms.1200120509

[8] NON-COMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION FOR ANY MODE OF ADMINISTRATION [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (03) : 372 - 373

[9] Rowland M, 1980, CLIN PHARMACOKINETIC

[10] SPRIET A, 1978, EUR J DRUG METAB PH, V2, P129